Seeger Weiss Named Litigators of the Week by Litigation Daily

By: Seeger Weiss on October 12, 2017

“You’re a pinch-hitter at an away game—the second in a double header—and you’re up to bat after the last pitch resulted in an eyepopping homerun. Six thousand are watching. Oh, and hundreds of millions of dollars are at stake,” was how The AmLaw Litigation Daily described partner David Buchanan’s remarkable bellwether win in the latest trial over the testosterone replacement therapy AndroGel, Konrad v. AbbVie, ending with a $140 million verdict on behalf of the client

 

The verdict came only 10 weeks after a similar verdict Mr. Buchanan secured in another trial in the multidistrict litigation, Mitchell et al. v. AbbVie Inc. et al., securing $150 million for the client.

For winning almost $300 million in combined damages in just the first two trials of the In re Testosterone Replacement Therapy Products Liability Litigation MDL, Seeger Weiss and Mr. Buchanan were recognized by Litigation Daily as their “Litigators of the Week.”

For more, read: How Teamwork Allowed Plaintiffs’ Lawyers to Pull Off a Nearly $300M AndroGel Double Header.

Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

Handling Cases Nationwide

we support

Free Case Evaluation Fill out the form for a Free Case Evaluation within 24 hours

By submitting this form I agree to the terms of SeegerWeiss.com Disclaimer and Privacy Policy

×